Modulating the developing gut microbiota with 2’-fucosyllactose and pooled human milk oligosaccharides
Abstract Background Synthetic human milk oligosaccharides (HMOs) are used to supplement infant formula despite limited understanding of their impact on the post-weaned developing gut microbiota. Here, we assess the influence of 0.5 g/L 2-fucosyllactose (2’FL) and 4.0 g/L pooled HMOs (pHMOs) on the c...
Saved in:
Main Authors: | Simone Renwick, Annalee Furst, Mikael Knip, on behalf of the DIABIMMUNE Study Group, Lars Bode, Jayne S. Danska, Emma Allen-Vercoe |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | Microbiome |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40168-025-02034-9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Research Progress in Compositions, Contents and Functions of Oligosaccharides in Breast Milk and Cow’s Milk
by: ZHANG Zhuoxing, XU Huihui, LIU Ruwei, ZOU Yunxia, AN Qin, ZHANG Yali
Published: (2024-12-01) -
Human milk oligosaccharides: bridging the gap in intestinal microbiota between mothers and infants
by: Wen Sun, et al.
Published: (2025-01-01) -
Structural characterization of oligosaccharide from Spirulina platensis and its effect on the faecal microbiota in vitro
by: Bingna Cai, et al.
Published: (2022-01-01) -
Interactions of human milk oligosaccharides with the immune system
by: Alanna S. Slater, et al.
Published: (2025-01-01) -
2’-Fucosyllactose alleviate immune checkpoint blockade-associated colitis by reshaping gut microbiota and activating AHR pathway
by: Shikai Yan, et al.
Published: (2024-09-01)